What is Acadia Pharmaceuticals Inc.'s Market Cap?

Acadia Pharmaceuticals Inc.'s Market Cap is $3.4B, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s Enterprise Value?

Acadia Pharmaceuticals Inc.'s Enterprise Value is $3.0B, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s Trailing P/E?

Acadia Pharmaceuticals Inc.'s Trailing P/E is 8.9×, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s Price / Sales?

Acadia Pharmaceuticals Inc.'s Price / Sales is 3.0×, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s EV / Revenue?

Acadia Pharmaceuticals Inc.'s EV / Revenue is 2.6×, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s EV / EBITDA?

Acadia Pharmaceuticals Inc.'s EV / EBITDA is 30.6×, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s Revenue (TTM)?

Acadia Pharmaceuticals Inc.'s Revenue (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s Net Income (TTM)?

Acadia Pharmaceuticals Inc.'s Net Income (TTM) is $380.5M, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s EBITDA?

Acadia Pharmaceuticals Inc.'s EBITDA is $98.4M, based on as-reported figures from SEC (XBRL) filings.

What is Acadia Pharmaceuticals Inc.'s Diluted EPS (TTM)?

Acadia Pharmaceuticals Inc.'s Diluted EPS (TTM) is 2.21, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Acadia Pharmaceuticals Inc.

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SB06N3

19.73▼ 0.58 (-2.86%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 20.31
Day's Range: 19.58 – 20.25
52-Week Range: 18.39 – 30.96
Volume: 1.0M
Avg Volume: 2.1M

Share Statistics

Shares Outstanding
Employees: 798
Exchange: XNAS
Listed: 2004-05-27

Share count as of July 28, 2026

Acadia Pharmaceuticals Inc. (ACAD) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Acadia Pharmaceuticals Inc. (ACAD)

What is Acadia Pharmaceuticals Inc.'s Market Cap?: Acadia Pharmaceuticals Inc.'s Market Cap is $3.4B, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s Enterprise Value?: Acadia Pharmaceuticals Inc.'s Enterprise Value is $3.0B, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s Trailing P/E?: Acadia Pharmaceuticals Inc.'s Trailing P/E is 8.9×, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s Price / Sales?: Acadia Pharmaceuticals Inc.'s Price / Sales is 3.0×, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s EV / Revenue?: Acadia Pharmaceuticals Inc.'s EV / Revenue is 2.6×, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s EV / EBITDA?: Acadia Pharmaceuticals Inc.'s EV / EBITDA is 30.6×, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s Revenue (TTM)?: Acadia Pharmaceuticals Inc.'s Revenue (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s Net Income (TTM)?: Acadia Pharmaceuticals Inc.'s Net Income (TTM) is $380.5M, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s EBITDA?: Acadia Pharmaceuticals Inc.'s EBITDA is $98.4M, based on as-reported figures from SEC (XBRL) filings.
What is Acadia Pharmaceuticals Inc.'s Diluted EPS (TTM)?: Acadia Pharmaceuticals Inc.'s Diluted EPS (TTM) is 2.21, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · ACADAs-filed SEC (XBRL) data